CLINICAL_TRIALS
trial_result
· 2010-02-10
Clinical Trial Update: 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064) [Phase 3]
Summary
Phase 3 extension study results for the sitagliptin and pioglitazone combination in type 2 diabetes were completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-02-10